Handelsavisen
prelaunch
Companies Healthcare 9265.T
92
9265.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

9265.T

¥3 000,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,12 %
Op margin
1,4 %
ROE
6,9 %
Net margin
1,0 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.

Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
6,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 9265.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 9265.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with cash and equivalents amounting to ¥5.698 billion, representing 20.7% of total assets. The absence of long-term debt and a debt-to-equity ratio of 0.0 indicate a conservative capital structure. The current ratio of 1.2 suggests adequate short-term liquidity to cover current liabilities.

    Profitability metrics show a return on equity (ROE) of 6.86% and a return on assets (ROA) of 2.24%. These figures are below the industry median for ROE and ROA, indicating that the company's profitability is lagging relative to its peers. The operating margin is 1.35%, and the net profit margin is 0.95%, both of which are below the industry median, suggesting that the company is underperforming in terms of cost control and pricing power.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business.

    The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The operating cash flow of ¥618 million and free cash flow of ¥355 million indicate a stable but not robust cash generation capability. The capital expenditure of ¥310 million suggests a moderate investment in future growth.

    Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and a strong cash position mitigate liquidity risk. However, the company's reliance on a single business segment and lack of geographic diversification pose concentration risks.

    Recent events include the latest actual EPS of 249.47 JPY and actual revenue of ¥64.486 billion JPY, as reported by analysts. No significant recent filings or transcripts have been disclosed that would indicate major strategic shifts or operational changes.

    Key takeaways
    • The company has a conservative capital structure with no long-term debt and a strong cash position.
    • Profitability metrics are below industry medians, indicating underperformance in terms of ROE and ROA.
    • The company's revenue is concentrated in a single business segment, increasing exposure to regional and regulatory risks.
    • Growth is modest, with stable but not robust cash generation capabilities.
    • Risk factors are low, with no immediate liquidity or dilution concerns.
    • "margin_outlook_rationale": "The company's operating and net profit margins are below industry medians, indicating potential inefficiencies in cost management and pricing power.",

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥3 000,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥8.98B
    Net cash
    ¥5.70B
    Current ratio
    1.2
    Debt / equity
    0.0
    ROA
    2.2%
    ROE
    6.9%
    Cash conversion
    100.0%
    CapEx / revenue
    -0.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin1,4 %Below median
    Net Margin1,0 %Below median
    ROE6,9 %Above median
    Capex / Rev-0,5 %Above P75
    D/E0,00Above P75
    Cash Conv1,00Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 9265.T Market data — financials · 2026-05-27
    • Yamashita Health Care Holdings Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    9265.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage